Top 50 Medical VC Funds & Investors in Spain (August 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Inveready
VC Fund
|
17 | Spain, United States, United Kingdom | Seed, Series A | Software, Biotechnology, Information Technology | $439k–$14M |
|
Centre for the Development of Industrial Technology (CDTI)
VC Fund
|
8 | Spain, United States, France | Grant, Seed | Biotechnology, Health Care, Software | $170k–$15M |
|
ENISA
VC Fund
|
8 | Spain, United States, France | Seed, Debt Financing, Pre-Seed | Software, Health Care, Artificial Intelligence | $66k–$1.6M |
|
CRB Inverbío
VC Fund
|
6 | Spain, Italy, Mexico | Series A, Seed | Health Care, Medical, Biotechnology | $2.2M–$8.9M |
|
Criteria Venture Tech
VC Fund
|
6 | Spain, United States, United Kingdom | Seed, Series A | Software, Biotechnology, E-Commerce | $256k–$21M |
|
Capital Cell
VC Fund
|
6 | Spain, France, United States | Equity Crowdfunding, Seed, Series A | Health Care, Biotechnology, Medical | $137k–$21M |
|
CDTI Innovación's INNVIERTE program
VC Fund
|
5 | Spain, Panama, Switzerland | Venture - Series Unknown, Seed | Biotechnology, Health Care, Medical | $266k–$16M |
|
SODENA
VC Fund
|
4 | Spain, United Kingdom | Debt Financing, Seed | Health Care, Biotechnology, Manufacturing | $37k–$1.2M |
|
Bio&Tech Smart Capital
VC Fund
|
4 | Spain | Series A, Venture - Series Unknown, Seed | Medical, Health Care, Pharmaceutical | $330k–$7.1M |
|
Asabys Partners
VC Fund
|
4 | Spain, France, Belgium | Series A, Series B, Seed | Health Care, Biotechnology, Medical Device | $1.3M–$135M |
|
EASO Ventures
VC Fund
|
4 | Spain, Switzerland | Seed, Venture - Series Unknown | Software, Health Care, Manufacturing | $229k–$4M |
|
BStartup - Banc Sabadell
VC Fund
|
4 | Spain, Mexico, United States | Seed, Pre-Seed | Software, Information Technology, Artificial Intelligence | $110k–$2.3M |
|
Clave Mayor
VC Fund
|
3 | Spain, Germany, United States | Seed, Series A | Software, Biotechnology, Medical | $262k–$8.9M |
|
MTIP AG
VC Fund
|
3 | United States, United Kingdom, Spain | Series A, Series B, Series C | Health Care, Medical, Artificial Intelligence | $1.5M–$80M |
|
Wellington Partners
VC Fund
|
3 | Germany, United States, United Kingdom | Series A, Series B | Health Care, Biotechnology, Medical | $3.1M–$60M |
|
Ysios Capital
VC Fund
|
3 | Spain, United States, Switzerland | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $3.8M–$135M |
|
Clave Capital
VC Fund
|
3 | Spain, Chile, Switzerland | Seed, Series A, Venture - Series Unknown | Biotechnology, Health Care, Software | $462k–$21M |
|
Encomenda VC
VC Fund
|
3 | Spain, France, United States | Seed, Pre-Seed | Software, SaaS, Information Technology | $146k–$3.6M |
|
Banco Sabadell
VC Fund
|
3 | Spain, United Kingdom, Mexico | Seed, Debt Financing, Series A | Software, E-Commerce, Internet | $252k–$1000M |
|
Kereon Partners
VC Fund
|
2 | Spain | Seed | Health Care, Cooking, Medical | $1.3M–$1.6M |
|
Ministry of Science and Innovation of Spain
VC Fund
|
2 | Spain | Grant, Seed, Pre-Seed | Biotechnology, Medical, Health Care | $841k–$2.5M |
|
Monte Carlo Capital
VC Fund
|
2 | United States, United Kingdom, Switzerland | Seed, Series A | Artificial Intelligence, FinTech, Software | $375k–$100M |
|
Innogest Capital
VC Fund
|
2 | Italy, United States, Spain | Series A, Series B | Health Care, Medical, Medical Device | $1.1M–$29M |
|
Medex Partners
VC Fund
|
2 | Spain | Pre-Seed | Medical, Health Diagnostics | |
|
Nara Capital
VC Fund
|
2 | Spain | Seed, Venture - Series Unknown, Series A | Life Science, Biotechnology, Medical | $394k–$7.3M |
|
GENESIS Biomed
VC Fund
|
2 | Spain | Seed, Pre-Seed, Venture - Series Unknown | Medical, Health Care, Pharmaceutical | $121k–$681k |
|
Orza Investments
VC Fund
|
2 | Spain | Venture - Series Unknown, Seed | Medical, Biotechnology, Medical Device | $1.1M–$19M |
|
Angels Capital
VC Fund
|
2 | Spain, United States, Kenya | Seed, Angel, Pre-Seed | Software, Health Care, SaaS | $104k–$2.5M |
|
European Investment Bank
VC Fund
|
2 | France, Germany, The Netherlands | Debt Financing, Post-IPO Debt | Biotechnology, Health Care, Energy | $16M–$726M |
|
AdBio partners
VC Fund
|
2 | France, Spain, Belgium | Seed, Series A, Venture - Series Unknown | Biotechnology, Health Care, Pharmaceutical | $2.2M–$37M |
|
Xesgalicia
VC Fund
|
2 | Spain, Portugal | Seed, Venture - Series Unknown | Software, Biotechnology, B2B | $304k–$5.9M |
|
Reig Jofre
VC Fund
|
2 | Spain | Seed, Venture - Series Unknown | Medical, Pharmaceutical, Biopharma | |
|
JME Ventures
VC Fund
|
2 | Spain, United States, Germany | Seed, Series A | Software, Information Technology, SaaS | $807k–$17M |
|
Alma Mundi Ventures
VC Fund
|
2 | Spain, United States, United Kingdom | Series A, Seed, Series B | Software, InsurTech, Insurance | $1.1M–$120M |
|
YZR Capital
VC Fund
|
2 | Germany, United Kingdom, Poland | Seed, Pre-Seed, Series A | Health Care, Medical, Artificial Intelligence | $742k–$52M |
|
Gestion De Capital Riesgo Del Pais Vasco
VC Fund
|
2 | Spain, Ecuador | Seed, Series A | Biotechnology, Health Care, Medical | $213k–$13M |
|
Eoniq.fund
VC Fund
|
2 | Spain, United States | Venture - Series Unknown, Seed, Pre-Seed | Artificial Intelligence, Health Care, Software | $115k–$1.7M |
|
Dozen Investments
VC Fund
|
2 | Spain, United Kingdom | Seed, Venture - Series Unknown, Pre-Seed | Software, Information Technology, Artificial Intelligence | $298k–$7.4M |
|
WA4STEAM
VC Fund
|
2 | Spain | Seed, Pre-Seed, Venture - Series Unknown | Health Care, Biotechnology, Artificial Intelligence | $392k–$11M |
|
AA Sons
VC Fund
|
2 | France, United States, Israel | Seed, Series A, Series B | Software, E-Commerce, FinTech | $1.1M–$74M |
|
Ancora Finance Group
VC Fund
|
2 | Spain, Germany | Series A | Medical, Medical Device, Health Care | $2.6M–$36M |
|
Speedinvest
VC Fund
|
2 | United Kingdom, Germany, Austria | Seed, Series A, Pre-Seed | Software, FinTech, Financial Services | $713k–$33M |
|
Adara Ventures
VC Fund
|
2 | Spain, United States, United Kingdom | Series A, Seed | Software, Information Technology, Artificial Intelligence | $1M–$14M |
|
ICF Capital
VC Fund
|
2 | Spain, United States, Mexico | Debt Financing, Seed | Software, Health Care, Artificial Intelligence | $110k–$6.9M |
|
Bionova Capital
VC Fund
|
2 | Portugal, United Kingdom, Spain | Seed, Series A, Venture - Series Unknown | Biotechnology, Medical, Health Care | $329k–$1.7M |
|
ICF - Institut Català de Finances
VC Fund
|
2 | Spain, Germany | Debt Financing, Seed | Health Care, Medical, Biotechnology | $1.7M–$12M |
|
Seed Capital Bizkaia
VC Fund
|
2 | Spain, Mexico, Belgium | Seed, Venture - Series Unknown | Software, Biotechnology, Manufacturing | $119k–$18M |
|
MSM
VC Fund
|
2 | United Kingdom, Portugal, Germany | Seed, Pre-Seed, Series A | Information Technology, E-Commerce, B2B | $244k–$52M |
|
Alta Life Sciences
VC Fund
|
2 | Spain, United States | Series A, Venture - Series Unknown, Series B | Biotechnology, Health Care, Therapeutics | $3M–$87M |
|
Norrsken VC
VC Fund
|
2 | Sweden, United Kingdom, Germany | Seed, Series A | Software, Artificial Intelligence, Health Care | $1.1M–$56M |
| Access all 227 VC funds in Spain Medical startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Inveready is a leading Spanish financial services firm focused on investment solutions and wealth management.
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Seed, Series A
- Geography: Spain, United States, United Kingdom
Investor stats
- Total investments: 203
- Round size: Seed $439k–$5.8M; Series A $1.6M–$14M
- Lead/follow: 45% lead, 55% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Voztelecom — VozTelecom develops software to enable Voice over Internet Protocol (VoIP) services over Internet. The company's products include miVoz.net, personal IP telephony service; intraVoz.net, local area network (LAN) IP telephony service with enhanced features; extraVoz.net, a hosted IP telephony service; vozConference.net, a hosted Web-conferenceservice with enhanced collaboration features; and wifiVoz.net, application that enables the usage of VozTelecom service through any wireless terminal. Voz has strategic alliances with Interxion, Cisco Systems, Iptel.org, SIP Phone, Jasomi Networks, Midworld Networks, and Endercom. The company was founded in 2003 and is headquartered in Cerdanyola, Spain.
- Inventia Kinetics — Inventia Kinetics specializes in the design, analysis, and manufacture of equipment and assembly tools for electronics sector.
- Telum Therapeutics — Telum Therapeutics is a biotechnology company that develops new treatments for infectious diseases based on the use of lytic enzymes from bacteriophages.
The Center for Industrial Technological Development (CDTI) is a public corporation under the Ministry of Economy and Competitiveness, which promotes innovation and technological development of Spanish companies. Is the entity which channels requests for funding and support to projects I + D + i of Spanish companies in the national andinternational levels. The CDTI has a staff of more than 300 people formed three quarters of engineers and graduates. Although the bulk of the infrastructure of the CDTI is located in Madrid, the Centre offers Spanish companies a strategic network of offices and representatives abroad (Japan -SBTO (Spain Business and Technology Office) - Belgium -SOST (Spain Office of Science and Technology) and Permanent Secretariat Eureka-, Brazil -FINEP (Financier of Studies and Projects) -, Korea, Chile, Morocco, China, India, Mexico and USA) to support them in their technological activities of type int .
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Grant, Seed
- Geography: Spain, United States, France
Investor stats
- Total investments: 217
- Round size: Seed $576k–$5.8M; Grant $170k–$15M
- Lead/follow: 41% lead, 59% follow
Portfolio highlights
- FuVeX — FuVeX is dedicated to the design, manufacture, and commercialization of drones. The vision of the members of FuVeX is to improve the way in which the great institutions and companies are related to the aeronautics. Moreover, the company's mission is to provide such institutions and companies with an aircraft that allows them to solve theirmonitoring or transportation needs by flying long distances in a safe, easy and legal way.
- Orga AI — Organ AI creates generative artificial intelligence that will help people. Its headquarters is located in Palma De Mallorca, Islas Baleares, Spain.
- Phoenix Foods — Phoenix Foods uses insect farming to solve the problems of organic waste management and the requirement for high-quality proteins in animal feed.
ENISA is a public company under the Ministry of Industry, Energy and Tourism, through the Directorate General of Industry and Small and medium-sized enterprises which, since 1982, actively participates in the financing of viable and innovative business projects.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Seed, Debt Financing, Pre-Seed
- Geography: Spain, United States, France
Investor stats
- Total investments: 231
- Round size: Seed $67k–$1.6M; Pre-Seed $165k–$1.2M; Debt Financing $66k–$489k
- Lead/follow: 43% lead, 57% follow
Portfolio highlights
- Naturr — Nature, which seeks to connect small-scale artisanal food producers from rural areas with urban consumers. Nature platform could serve as an important bridge for promoting local and sustainable food systems, benefiting both rural producers and urban consumers i
- Biotasmart — Plataforma que convierte datos de la microbiota intestinal en recomendaciones nutricionales personalizadas.
- DARWIN Biomed — Biomedical Engineering
CRB Inverbio is a private venture capital management firm specialized in life sciences investing in innovative early stage start- ups in biotech, med tech, digital health and medical technologies
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Series A, Seed
- Geography: Spain, Italy, Mexico
Investor stats
- Total investments: 16
- Round size: Seed $3.3M–$5.3M; Series A $2.2M–$8.9M
- Lead/follow: 31% lead, 69% follow
- Last fund: May invest from a new fund soon — raised $70M in 2010
Portfolio highlights
- Nuubo — Nuubo is a Spanish medical device company that develops wireless, wearable technologies to monitor physiological parameters. To do so, Nuubo has a platform known as nECG DYNAMIC PLATFORM, which makes it easier to perform and read an electrocardiogram remotely. Specifically, the system patented by Nuubo is made up of three elements: a biomedicalgarment that allows the electrocardiogram signal to be captured without interfering with the patient’s daily activity; a device that continuously records the information captured by the garment and which also allows the data to be sent wirelessly and in real time for processing; and analysis and visualization software that, using artificial intelligence algorithms, can interpret all of the information transmitted by the wireless device.The devices designed by Nuubo allow patients’ hearts to be monitored for longer periods of time and without feeling uncomfortable or intrusive. The company is headquartered in Madrid, Spain.
- Prosoma — Prosoma was born out a need to provide more comprehensive care for cancer patients. We have found a fundamental lack of access to psychological care for patients who not only have to face a life-altering disease and treatment, but also crucially have a different set of needs than other psychological patients. Barriers to accessing psychologicalcare often include low numbers of therapists and clinicians in the area, financial or geographical limitations, and the general wellbeing of patients preventing them from attending meetings. All of these issues can be solved by modern technology.By using VR as part of, or when necessary, an alternative to traditional psychological treatment, we can reach patients that would otherwise be left without any support. They can use our tool at home or in the clinics whilst undergoing pharmacological treatment and chemotherapy.We hope to provide patients with a tool that will help them manage stress, cope with the burden of cancer, and eventually improve their quality of life.
- Carol — Carol is a tech-enabled healthcare provider delivering membership-based primary care services, on a mission to make high-quality healthcare accessible and affordable for everyone. To achieve this goal, Carol leverages a highly scalable technology, combined with high quality clinical operations and a salaried provider model.
Criteria Venture Tech is the tech VC fund of CriteriaCaixa which invests in B2B SaaS and DeepTech companies in early and growth stages (Seed to Series B) managing more than €300M of AUM.
Show more...Investment focus
- Industry: Software, Biotechnology, E-Commerce
- Stage:Seed, Series A
- Geography: Spain, United States, United Kingdom
Investor stats
- Total investments: 158
- Round size: Seed $256k–$3.8M; Series A $1.9M–$21M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- 8Layers — 8Layers is an artificial intelligence platform that offers cloud identity threat detection to organizations
- Barbara — Barbara is the Cybersecure Industrial Edge Platform that enables companies to connect, deploy and scale gateways and edge applications in a few clicks
- iPronics — iPronics develops the innovative concepts of general-purpose integrated programmable photonic systems.
Capital Cell is a crowdinvesting platform for biotech and life sciences companies. Mixing VC, business angels, accredited investors, and the power of the crowd, the company is building a global meeting point for companies and researchers working, fostering, and financing tomorrow’s medical science.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Equity Crowdfunding, Seed, Series A
- Geography: Spain, France, United States
Investor stats
- Total investments: 52
- Round size: Seed $384k–$1.9M; Series A $1.1M–$21M; Equity Crowdfunding $137k–$1.5M
- Lead/follow: 27% lead, 73% follow
Portfolio highlights
- DYNAMICS VR — Dynamics VR provides rehab software for clinics to tackle musculoskeletal pain and movement impairments caused by brain trauma.
- Axoltis Pharma — Axoltis Pharma is a biotech company that develops drugs for degenerative and traumatic neurological disorders.
- EVis Bioscience — EVis Bioscience develops innovative gene delivery systems for targeted and personalized medicine. This includes extracellular vesicles, synthetic lipid nanoparticles, and their hybrids.
CDTI Innovación's INNVIERTE program is part of the Spanish Science, Technology, and Innovation Strategy. This Strategy is one of the cornerstones around which the Government's R&D&I strategy for the upcoming years is built. It outlines the goals, changes, and actions that must be implemented across the R&D&I sector inorder to maximize its growth and effect.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Venture - Series Unknown, Seed
- Geography: Spain, Panama, Switzerland
Investor stats
- Total investments: 52
- Round size: Seed $266k–$6.4M; Venture - Series Unknown $330k–$16M
- Lead/follow: 37% lead, 63% follow
Portfolio highlights
- Zoundream — The Future of Infant Care
- Ona Therapeutics — Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. Founded in 2019 by Salvador Aznar-Benitah and Valerie Vanhooren, it was a spin-off from ICREA and Advanced Studies, and the IRB Institute for Research in Biomedicine.
- Telum Therapeutics — Telum Therapeutics is a biotechnology company that develops new treatments for infectious diseases based on the use of lytic enzymes from bacteriophages.
SODENA is the main instrument of the Government of Navarre for the business development of the region. SODENA carries out its activities as a public limited company, with a majority direct shareholding of 65.42% by the Government of Navarre, and an indirect participation through Nafinco (14.58%). It also participates in the shareholding of GrupoCorporativo Empresarial Caja Navarra (20%), through TME 2001 CorpCan, S.L.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Manufacturing
- Stage:Debt Financing, Seed
- Geography: Spain, United Kingdom
Investor stats
- Total investments: 91
- Round size: Seed $110k–$1.2M; Debt Financing $37k–$743k
- Lead/follow: 32% lead, 68% follow
Portfolio highlights
- FuVeX — FuVeX is dedicated to the design, manufacture, and commercialization of drones. The vision of the members of FuVeX is to improve the way in which the great institutions and companies are related to the aeronautics. Moreover, the company's mission is to provide such institutions and companies with an aircraft that allows them to solve theirmonitoring or transportation needs by flying long distances in a safe, easy and legal way.
- Muxunav — Muxunav specialize in digital payment systems, they might be working on technologies like mobile payment solutions, online transaction systems, digital wallets, or even blockchain-based payment methods.
- El Caserío de Tafalla — El Caserío de Tafalla is a food production company that processes and supplies a variety of candies.
Bio&Tech Smart Capital is the alliance of researchers and entrepreneurs with Venture Capital management professionals to transfer scientific knowledge to society.
Show more...Investment focus
- Industry: Medical, Health Care, Pharmaceutical
- Stage:Series A, Venture - Series Unknown, Seed
- Geography: Spain
Investor stats
- Total investments: 6
- Round size: Venture - Series Unknown $330k–$7.1M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Oncostellae — Oncostellae is a biotechnology startup developing small-molecule drugs with innovative scaffolds (NCEs) that modulate clinically validated therapeutic targets in oncology and inflammatory/autoimmune diseases.
- Pharmacelera — Improving pharmaceutical R+D productivity through a lean drug discovery process based on advanced computational methodologies.
- ADNTRO Genetics — DNA test with saliva sample. Find out all about your health, nutrition, wellness and ancestry. Fast and private results.
Fostering breakthrough innovation in healthcareAsabys is an investment firm based in Barcelona, investing in healthcare and life-sciences innovation. PORTFOLIO TEAM Impact We want to push the boundaries of science and medicine improving patient's life Disruptive We look for highly innovative and transformative technologies Hands-on We consider ourselves partners and collaborators to our portfolio
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Series B, Seed
- Geography: Spain, France, Belgium
Investor stats
- Total investments: 38
- Round size: Seed $1.3M–$13M; Series A $7M–$57M; Series B $18M–$135M
- Lead/follow: 50% lead, 50% follow
- Last fund: Likely still investing — raised $117M in 2022
Portfolio highlights
- Orikine Bio — Orikine Bio is a pioneer biotech company in the field of tailored cytokines with unmatched biological properties for the treatment of immune-mediated disorders.
- Splice Bio — Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations ofadeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.
- Ona Therapeutics — Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. Founded in 2019 by Salvador Aznar-Benitah and Valerie Vanhooren, it was a spin-off from ICREA and Advanced Studies, and the IRB Institute for Research in Biomedicine.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Easo Ventures es una Sociedad de Capital Riesgo Vasca y Privada, cuyo objetivo es invertir en Startups y PYMES con proyectos de crecimiento.
Show more...Investment focus
- Industry: Software, Health Care, Manufacturing
- Stage:Seed, Venture - Series Unknown
- Geography: Spain, Switzerland
Investor stats
- Total investments: 77
- Round size: Seed $266k–$3.2M; Venture - Series Unknown $229k–$4M
- Lead/follow: 26% lead, 74% follow
Portfolio highlights
- Energiot — Energiot specialized engineering service in energy harvesting, self-powered devices, wireless sensor networks.
- DYNAMICS VR — Dynamics VR provides rehab software for clinics to tackle musculoskeletal pain and movement impairments caused by brain trauma.
- DARWIN Biomed — Biomedical Engineering
A Banc Sabadell initiative to support young companies in developing their projects. Bstartup is designed to support entrepreneurs so their projects can be developed with maximum guarantees of success. - Investment and growth - Specialized products and branches - Collaborative innovation
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Pre-Seed
- Geography: Spain, Mexico, United States
Investor stats
- Total investments: 84
- Round size: Seed $110k–$2.3M; Pre-Seed $219k–$900k
- Lead/follow: 44% lead, 56% follow
Portfolio highlights
- TietAI — TietAI is the agentic integration layer for hospitals, payers and digital health, unifying HL7, FHIR, X12 and DICOM into one governed plane.
- Energiot — Energiot specialized engineering service in energy harvesting, self-powered devices, wireless sensor networks.
- Floatech — Discover Floatech: Boosting lithium-ion batteries with sustainable, high-performance silicon anodes. Explore our innovative technology.
Clave Mayor is a management company of closed investment entities based in Navarra.
Show more...Investment focus
- Industry: Software, Biotechnology, Medical
- Stage:Seed, Series A
- Geography: Spain, Germany, United States
Investor stats
- Total investments: 33
- Round size: Seed $262k–$5.5M; Series A $2.2M–$8.9M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- MOA — MOA make healthy food for a sustainable world that solves growing global food demands. They are establishing a new industry of sustainable food that solves growing global food demands without the need for arable land. They are focused on designing high-value, natural and nutritious food.
- Ojer Pharma — Ojer Pharma engages in the research, development, production, and marketing of dermopharmaceutical products in Spain. It develops prescription medicines, cosmetics, and medical devices. The company has developed a vehiculization technology in the form of bioadhesive transparent gels, which acts as a sustained-release matrix of dermatologicalactives, such as lipophilics and hydrophilics.
- Semi Zabala — Welcome to Semi Zabala, a pioneering semiconductor company dedicated to innovation and excellence. Our mission is to push boundaries and enhance technology, embodying our slogan: beyond the power. Explore our advanced solutions designed for a smarter, more connected future.
MTIP is a growth capital investor that specializes in scaling up healthtech companies in rapidly expanding global markets. Visit our website!
Show more...Investment focus
- Industry: Health Care, Medical, Artificial Intelligence
- Stage:Series A, Series B, Series C
- Geography: United States, United Kingdom, Spain
Investor stats
- Total investments: 28
- Round size: Series A $1.5M–$36M; Series B $10M–$30M; Series C $9.3M–$80M
- Lead/follow: 57% lead, 43% follow
- Last fund: Likely still investing — raised $250M in 2021
Portfolio highlights
- TrialBee — Trialbee is revolutionizing clinical trials with innovative global patient recruitment solutions. Streamline your recruitment process today.
- Verifarma — Verifarma offers comprehensive, robust & high-quality services to drugs, medical products, chemical precursors, agrochemicals.
- NitiNotes — Nitinotes has developed the EndoZipTM, a fully automated, operator independent gastroscopic suturing system, allowing gastroenterologists as well as surgeons to bring a durable solution to their patients. The procedure creates an effect of stomach volume restriction and motility impair - both are needed to help obese patients reducing weight.
Wellington Partners is a venture capital firm that invests in technology and life sciences companies, focusing on Digital Media, Software, Electronics & Photonics, Resource Efficiency, and Biotech/Life Sciences. It is committed to providing outstanding entrepreneurs with the necessary resources to fund their strategies. We typically leadfinancing rounds ranging from € 0.5 million to € 20 million. Depending on the maturity of the company, its own commitment can go as high as € 15 million.Wellington was established in 1998 and has offices in Munich, London, and Zurich.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B
- Geography: Germany, United States, United Kingdom
Investor stats
- Total investments: 201
- Round size: Series A $3.1M–$36M; Series B $8.3M–$60M
- Lead/follow: 30% lead, 70% follow
- Last fund: May invest from a new fund soon — raised $222M in 2019
Portfolio highlights
- nyra health — nyra health is an artificial intelligence and evidence-based neurological research tablet app that offers a revolutionary form of therapy. nyra health was founded in 2020 and was headquartered in Vienna, Austria.
- Nuclidium — NUCLIDIUM is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for precision diagnostics. Using copper isotopes, Copper-61 for diagnostics and Copper-67 for therapeutics, the company is creating a differentiated platform with the potential to overcome existing limitations in radiotheranostics.
- Beren Therapeutics — Founded to serve patients through transformative medicines
Leading #lifesciences #venturecapital firm financing highly #innovative #biotechnology companies #worlwide.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: Spain, United States, Switzerland
Investor stats
- Total investments: 81
- Round size: Series A $3.8M–$62M; Series B $20M–$135M; Series C $27M–$80M
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- AM Pharma — AM-Pharma B.V., a biopharmaceutical company, engages in the development and commercialization of therapeutics for human use in the Netherlands. It focuses in the pre-clinical and clinical development of novel therapeutics to treat inflammatory and infectious diseases. The company develops products based on endogenous proteins and protein derivedpeptides, as well as molecules that naturally occur in the human body. Its products include alkaline phosphatase for treatment of acute kidney injury and ulcerative colitis; and immune response amplifying peptide hLF1-11 for the treatment of drug resistant hospital acquired infections. The company was founded in 2000 and is headquartered in Bunnik, the Netherlands.
- Inbiomotion — Inbiomotion is focused on the development and commercialization of a biomarker that predicts metastasis to improve patients' quality of life by personalizing the adjuvant treatment of early stage breast cancer. Founded in 2010 by Dr. Roger Gomis, it is a spin-off of IRB Barcelona and ICREA research institutions.Inbiomotion's uniquediagnostic assay is based on a highly selective single gene biomarker. Data generated thus far suggests such biomarker can identify early stage breast cancer patients that will benefit from bisphosphonate adjuvant treatment improving their overall and invasive disease free survival. It can further predict at an early stage a patient's risk of metastases relapse from primary tumors. The selectivity of the lead biomarker has the potential to advance the clinical standard of care using personalized medicine.
- Splice Bio — Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations ofadeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.
Clave is an investment management company.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Spain, Chile, Switzerland
Investor stats
- Total investments: 45
- Round size: Seed $462k–$5.5M; Series A $3.2M–$21M; Venture - Series Unknown $541k–$7.1M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely still investing — raised $53M in 2023
Portfolio highlights
- Sensesbit — Sensesbit is a SaaS market research platform focused on sensory intelligence for the food and beverage industry, developed by TasteLab to analyze and predict product market acceptance . The tool integrates advanced statistical analysis, AI for benchmarking, and computer vision tools to manage sensory testing with consumers and trained panels. Learnmore about the platform on the official Sensesbit website.
- D-Sight — D-Sight is an early treatment for the leading cause of preventable blindness in the working-age population.
- Telum Therapeutics — Telum Therapeutics is a biotechnology company that develops new treatments for infectious diseases based on the use of lytic enzymes from bacteriophages.
Encomenda is a Venture Capital specialized in seed investments in technology startups. They open the door to investors and professional business angels to capitalize on their investments through collective investment vehicles. They minimize investment risks thanks to the diversification of the portfolio and preferential access to the best projectsin search of financing.
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Seed, Pre-Seed
- Geography: Spain, France, United States
Investor stats
- Total investments: 90
- Round size: Seed $341k–$3.6M; Pre-Seed $146k–$948k
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely still investing — raised $15M in 2024
Portfolio highlights
- Tripjoin — Tripjoin brings together those who want to travel but don't have anyone to travel with. Everyone joined with the same goal of meeting new people and experiencing travel in a unique way.
- Uxia — Transform your research with AI-powered user testing, delivering high-quality UX/UI insights for Product Designers and UX Researchers. No recruiting needed.
- Mathew — Mathew is an educational platform that provides AI-powered software for teachers and students.
Banco Sabadell is a banking group that specializes in serving small and medium enterprises. It comprises of several banks, brands, subsidiaries, and associated banks. The company was founded in 1881 and is headquartered in Alicante, Spain.
Show more...Investment focus
- Industry: Software, E-Commerce, Internet
- Stage:Seed, Debt Financing, Series A
- Geography: Spain, United Kingdom, Mexico
Investor stats
- Total investments: 78
- Round size: Seed $252k–$6.5M; Series A $1M–$20M; Debt Financing $3M–$1000M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- Sonnedix — Sonnedix is an Independent Solar Power Producer (IPP) with a proven track record in delivering high performance cost competitive solar photovoltaic plants to the market.
- NeuralTrust — NeuralTrust is the leading security platform for generative AI, offering a unified command center for real-time defense and offense. Its open source AI gateway delivers the fastest performance in the market for managing LLM traffic, while its automated red teaming engine proactively uncovers vulnerabilities, ensuring robust protection for your AIsystems.
- Catalonia Hotels & Resorts — Catalonia Hotels & Resorts is a hotel chain that offers loyalty program to take care of the customer's stay.
> smart projects
Show more...Investment focus
- Industry: Health Care, Cooking, Medical
- Stage:Seed
- Geography: Spain
Investor stats
- Total investments: 4
- Round size: Seed $1.3M–$1.6M
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Qualityfry — If you are looking for an automatic commercial deep fryer for your business, check the QualityFry ones. Check out and request a demonstration
- Persei vivarium (Digital Health) — Persei vivarium is a digital health business dedicated to the creation of high-quality data collections that are based on real-word data for specific diseases. The technology facilitates the capture of clinical data from the physician’s daily clinicalpractice and from the patient based on a mobile appication for remote monitoring. This provides a more holistic view and better management of the disease. The information that is captured becomes a high-value resource that also, in a simple and easy process, generates high-quality research.
- Transplant Biomedicals — Transplant Biomedicals is a European company based in Barcelona aimed at developing novel medical strategies to improve organ, tissue and cellular preservation to overall enhance patients´ wellness.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Ministry of Science and Innovation of Spain provides policies for universities, scientific and technical research, technological development
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Grant, Seed, Pre-Seed
- Geography: Spain
Investor stats
- Total investments: 7
- Round size: Grant $841k–$2.5M
- Lead/follow: 86% lead, 14% follow
Portfolio highlights
- Orikine Bio — Orikine Bio is a pioneer biotech company in the field of tailored cytokines with unmatched biological properties for the treatment of immune-mediated disorders.
- Gyala Therapeutics — Gyala Therapeutics is focused on developing new CAR-T therapies for treating hematological malignancies. CAR-T (chimeric antigen receptor T cells) is a type of gene therapy in which T lymphocytes -a type of white blood cells that play a key role in immune responses- are extracted from the patient and modified to attack tumour cells. T lymphocytesare obtained through apheresis (a technique that allows separation of blood components) and genetically reprogrammed with a receptor that binds to a tumor factor. When these cells are transduced back to the patient, they are to specifically recognize tumour cells and attack them. Several types of CAR-T cells have demonstrated efficacy in the treatment of leukemias and B cell lymphomas.
- Oniria Therapeutics — Modulating cell dormancy to overcome cancer persistence
Discover Monte Carlo Capital, a leading angel investment firm supporting early-stage startups in technology.
Show more...Investment focus
- Industry: Artificial Intelligence, FinTech, Software
- Stage:Seed, Series A
- Geography: United States, United Kingdom, Switzerland
Investor stats
- Total investments: 67
- Round size: Seed $375k–$9.3M; Series A $1.3M–$100M
- Lead/follow: 34% lead, 66% follow
Portfolio highlights
- Algorized — Algorized develops advanced technologies for human presence detection using UWB Radar.
- Ratio — A new way to finance subscription companies without dilution offering flexibility to help you thrive and compete. Put your recurring revenue to work.
- Scout AI — Scout AI is building the robotic foundation model for defense.
We are investors in companies that make the difference. We partner with hard-working entrepreneurial visionaries
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Series A, Series B
- Geography: Italy, United States, Spain
Investor stats
- Total investments: 68
- Round size: Series A $1.1M–$11M; Series B $2.7M–$29M
- Lead/follow: 37% lead, 63% follow
- Last fund: May invest from a new fund soon — raised $99M in 2015
Portfolio highlights
- Newronika — Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normaldaily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
- Renovacor — Renovacor is a preclinical‑stage biopharmaceutical company focused on developing transformative gene therapy‑based treatments for cardiovascular disease.Renovacor’s lead program is a recombinant adeno-associated virus (AAV)‑based gene therapy for patients suffering from dilated cardiomyopathy (DCM) due to mutations in the Bcl2‑associatedathanogene 3 (BAG3) gene.Dilated cardiomyopathy is a condition affecting over 3 million patients in the US and growing steadily. Many patients develop DCM due to ischemic heart disease. Recently subpopulations have been identified that develop DCM due to mutations in specific genes that have been shown to result in the development of DCM. One of these specific genes is the BAG3 gene. The prevalence of disease‑causing BAG3 haploinsufficiency is estimated at approximately 35,000 individuals in the United States, representing an orphan disease by FDA guidelines. It is estimated a similar number of DCM patients with BAG3 mutations exist in Europe. These patients are typically younger and progress to end-stage heart failure sooner than patients with ischemic heart disease. Currently, DCM patients with a BAG3 mutation are treated with standard of care for heart failure. Despite improvements in pharmacotherapy and care, the five‑year survival of a patient with DCM is only 50%. The development of a BAG3 gene replacement therapy for patients with DCM that carry BAG3 mutations could potentially prevent the progression of disease in this otherwise healthy population of young adults.
- BetaGlue Technologies — BetaGlue Therapeutics develops innovative targeted cancer therapy solutions using its proprietary YntraDose technology for nuclear medicine.
Medex Partners is an investment club focused on healthcare that is led by entrepreneurs and industrial companies with broad experience in the sector.
Show more...Investment focus
- Industry: Medical, Health Diagnostics
- Stage:Pre-Seed
- Geography: Spain
Investor stats
- Total investments: 2
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Manina Medtech — We created Seedchrony, first in class device to assess endometrial receptivity for embryo transfer, we are Manina Medtech | Boosting IVF Success
As asset managers, we invest on behalf of third parties. Our fear of losing their money is greater than the fear of losing an opportunity. Our investment style consists of value orientation, specialization and trust, applying our investment criteria in a disciplined way. We invest to transform the companies into industry leaders. With a hands-onapproach, Nara invests in assets enhancing its value with a long-term view. We are a highly experienced team with the patience and tenacity required to see deals through, committing our own money. We create value in a sustainable way, investing in a responsible way to generate a positive impact on the community. We analyze each investment in detail in order to create shared value for our investors, partners, customers, suppliers and workers.
Show more...Investment focus
- Industry: Life Science, Biotechnology, Medical
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Spain
Investor stats
- Total investments: 10
- Round size: Seed $394k–$7.3M; Venture - Series Unknown $1.9M–$3.3M
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- Aortyx — With a focus on aortic dissection, Aortyx has developed a bioresorbable endovascular patch designed to seal the entry tear, delivered through a proprietary dual-steerable catheter.
- MiMARK — MiMARK specializes in developing in vitro diagnostic solutions to improve the management of gynecological malignancies. The company envisions the gynecological fluid as the next step in liquid biopsy in gynecology. MiMARK 's first objective is to improve endometrial cancer diagnosis.
- Neboda — We are an indoor vertical farming company that combines combines a scientific approach and an industrial automation background.
Life sciences R&D, consulting and investment
Show more...Investment focus
- Industry: Medical, Health Care, Pharmaceutical
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: Spain
Investor stats
- Total investments: 4
- Round size: Seed $121k–$681k
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Thytech — Thytech is a health tech company.
- Affirma Biotech — Affirma Biotech develops new orally available immunotherapeutic drugs for the treatment of severe infections and cancer
- Ownmed Innovation — Ownmed Innovation is a Medtech spin-off that emerged from the collaboration between the Fundación para la Investigación Biomédica Hospital Gregorio Marañón (FIBHGM), the Instituto Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD) and Universidad Carlos III de Madrid (UC3M). Its main objective is the development of a medical device, Ostofix®,aimed at ostomate patients, with the purpose of restoring their ability to regain control over their continence.
ORZA is a direct investment entity, part of the ELKARKIDETZA and GEROA pension funds, which deals with the acquisition of shares in businesses.It supports the Basque business sector through expansion and internationalisation projects, MBO and MBI transactions, to resolve questions of corporate succession and in the substitution of minorityshareholders.
Show more...Investment focus
- Industry: Medical, Biotechnology, Medical Device
- Stage:Venture - Series Unknown, Seed
- Geography: Spain
Investor stats
- Total investments: 8
- Round size: Seed $1.1M–$5M; Venture - Series Unknown $1.2M–$19M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- SATLANTIS — Scientific space technology for Earth observation and space monitoring, delivering reliable observational data.
- Mikrobiomik — Mikrobiomik is a biopharmaceutical company that provides innovative solutions for chronic diseases.
- Deneb Medical — Deneb Medical is a start-up dedicated to developing a robotic platform for applications in neurosurgery, CMF surgery, head and neck surgery, urology and general surgery.
Angels Capital philosophy is to find and support at 1 able to lead a project. Their goal is to support the entrepreneurial, helping to create new businesses, help grow their business sector, generate employment and create wealth.
Show more...Investment focus
- Industry: Software, Health Care, SaaS
- Stage:Seed, Angel, Pre-Seed
- Geography: Spain, United States, Kenya
Investor stats
- Total investments: 135
- Round size: Seed $265k–$2.5M; Angel $104k–$1.5M; Pre-Seed $323k–$994k
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Citring — Citring One, is an innovative juicer with a radically simplified process. Effortless from juicing to cleaning, it is ideal for anyone with a busy lifestyle. Say goodbye to hassle and hello to fresh juice. With Citring One, juicing is as easy as pressing a button.
- Trak — Trak is a software tool for healthcare professional to provide AI-based tele-rehabilitation services like physiotherapy and others.
- Cocircular — Cocircular is a Construction Company.
The European Investment Bank (EIB) offers lending, borrowing, and treasury services primarily within the European Union. It provides project loans for public and private sectors, loans to banks and intermediaries, structured finance products, guarantees, and securitization instruments for debts. Additionally, EIB offers equity and fund investmentproducts, including infrastructure and environmental funds, as well as venture capital funds. EIB also supports microfinance and risk-sharing finance for research and innovation, and provides technical expertise for sustainable energy projects. Its services include infrastructure advisory, urban development support, guarantees for transport infrastructure, and funding for public-private partnerships and small- to medium-sized enterprises. The bank serves various sectors, including transportation, energy, health, education, and agriculture.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Energy
- Stage:Debt Financing, Post-IPO Debt
- Geography: France, Germany, The Netherlands
Investor stats
- Total investments: 520
- Round size: Post-IPO Debt $18M–$726M; Debt Financing $16M–$352M
- Lead/follow: 83% lead, 17% follow
Portfolio highlights
- Ukrposhta — Ukrposhta sends and receives shipments from all over the world, as well as orders mail products sent to the most distant corners.
- IPT PowerTech — IPT PowerTech coverage, coupled with our extensive expertise in supply chain management, field implementation, and power systems, has made us one of the most capable companies in handling the most complicated and versatile projects in the MEA region and its neighboring countries.
- Santander Brasil — Banco Santander in Brazil, its largest division in Latin America and one of the world's most important, accounting for 50%.
AdBio partners is a European Life Sciences Venture Capital firm dedicated to seeding healthcare’s step forward.We work with leading research institutions and well-established technology transfer offices, with a strong network of scientific and medical partners, exploring new territories to source breakthrough medical discoveries and driveinventive Life Sciences start-ups to success.We embrace European Life Sciences’ dynamic of innovation. Europe harbors a vibrant environment for medical and scientific investigation, with some of the most leading-edge academic and research centers. AdBio partners seizes the opportunity to highlight their undervalued research programs and assets and participate in structuring Europe’s biotechnology ecosystem.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: France, Spain, Belgium
Investor stats
- Total investments: 32
- Round size: Seed $2.2M–$18M; Series A $18M–$37M; Venture - Series Unknown $2.2M–$16M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $116M in 2021
Portfolio highlights
- Orikine Bio — Orikine Bio is a pioneer biotech company in the field of tailored cytokines with unmatched biological properties for the treatment of immune-mediated disorders.
- ARTHEx Biotech — ARTHEx Biotech S.L. is a spin-off company of the University of Valencia that is developing advanced RNA treatments against genetic diseases.
- Integra Therapeutics — Integra Therapeutics is a developer of next generation of gene editing tools to cure diseases.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!XesGalicia is a Galician Venture Capital Management firm. It finances company development through the temporary acquisition of minority shares of the capital of unquoted companies.
Show more...Investment focus
- Industry: Software, Biotechnology, B2B
- Stage:Seed, Venture - Series Unknown
- Geography: Spain, Portugal
Investor stats
- Total investments: 34
- Round size: Seed $304k–$5.9M; Venture - Series Unknown $904k–$5.5M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- Kreios Space — Kreios Space is developing an electric propulsion system to revolutionize the satellite industry. With this technology we enable orbital keeping in VLEO (Very Low Earth Orbits) thanks to renewable energy. We make space applications easier.
- VigSec-Drone — VigSec-Drone is a high-performance security and surveillance designed to deliver real-time situational awareness.
- Iteria Biopharma — PROFESSIONAL TEAM User can utilize his smartphone to pay for a wide range of services or any CONSULTATION User can utilize his smartphone to pay for a wide range of services or any TREATMENT User can utilize his smartphone to pay for a wide range of services or any First-in-class NCEs addressed to modulate challenging
Reig Jofre is a manufacturer of pharmaceutical products. The company produces drugs, penicillin antibiotics, and other pharmaceutical products.
Show more...Investment focus
- Industry: Medical, Pharmaceutical, Biopharma
- Stage:Seed, Venture - Series Unknown
- Geography: Spain
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Vaxdyn — Preventing the next global health crisis Our mission is to prevent and alleviate the global health crisis caused by the pathogenic bacteria resistant to ant ...
- Affirma Biotech — Affirma Biotech develops new orally available immunotherapeutic drugs for the treatment of severe infections and cancer
We help build cutting-edge companies like Flywire. Flywire's trusted and secure global payment platform keeps your money moving around the world.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Seed, Series A
- Geography: Spain, United States, Germany
Investor stats
- Total investments: 129
- Round size: Seed $807k–$6.3M; Series A $3.5M–$17M
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — raised $70M in 2019
Portfolio highlights
- Tolemy Bio — The AI-native virtual cell platform for therapeutic development and manufacture.
- Charms — Charms AI is an on‑chain mobile application focused on AI characters with persistent memory and user‑facing economies. The platform allows creators to build AI characters that can maintain long‑term conversational context and have their own wallets and tokenized assets, while users interact with, back, and trade around those characters. It sits atthe intersection of AI‑driven interaction, gaming‑style engagement, and blockchain‑based tokenization, with the overall design geared toward converting user attention and interaction into on‑chain economic flows.
- Balance — Balance is a private digital health company based in Spain that operates in the clinics and outpatient healthcare services sector. company's core mission is to provide an integrated, medical, and sustainable approach to treating obesity and overweight conditions. Moving away from traditional restrictive diets, the company leverages asubscription-based telehealth model combined with clinical pharmacology.
We back bold and purpose-driven founders.
Show more...Investment focus
- Industry: Software, InsurTech, Insurance
- Stage:Series A, Seed, Series B
- Geography: Spain, United States, United Kingdom
Investor stats
- Total investments: 123
- Round size: Seed $1.1M–$9.9M; Series A $2.7M–$30M; Series B $5M–$120M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- Convelio — Convelio is a global logistics startup specialized in bulky, fragile and high-value items.
- Parametrix — Parametrix cloud insurance protects companies against any loss due to cloud outages. A simple, essential add-on to any cyber program.
- Sherpa.ai — Secure AI. Private Data. Sovereign Intelligence. Sherpa.ai platform enables secure distributed AI deployments across enterprises, governments, and regulat
We back ambitious HealthTech founders solving complex healthcare challenges. We provide capital, deep sector expertise, and hands-on support to build global champions.
Show more...Investment focus
- Industry: Health Care, Medical, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: Germany, United Kingdom, Poland
Investor stats
- Total investments: 35
- Round size: Seed $2.5M–$5.5M; Pre-Seed $742k–$2.5M; Series A $10M–$52M
- Lead/follow: 63% lead, 37% follow
- Last fund: Likely still investing — raised $70M in 2022
Portfolio highlights
- Biorce — Meet the world's first AI clinical trials assistant! We bring innovative technologies to revolutionize healthcare and drug development faster & more efficiently
- dehaze — dehaze provides healthcare services by bringing medical AI models into clinical practice.
- Scripta Therapeutics — Biology decoded, disease undone - modulating transcription factors to restore health
Gestión de Capital Riesgo del PaÃs Vasco SGECR, S.A. is a venture capital entity management company founded in 1985 by the Basque Government as part of the Sociedad para la Promoción y Reconversión Industrial (SPRI), with the aim of promoting and developing venture capital activity in the Basque Country.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A
- Geography: Spain, Ecuador
Investor stats
- Total investments: 23
- Round size: Seed $213k–$2.3M; Series A $329k–$13M
- Lead/follow: 35% lead, 65% follow
- Last fund: May invest from a new fund soon — last raise in 2014
Portfolio highlights
- InspectRail — InspectRail was established to offer high-quality information on the state of railway infrastructure, thereby enhancing its operation, management, and maintenance.
- Orbik Cybersecurity — Orbik Cybersecurity provides testing and compliance services for industrial equipment and embedded electronics.
- Inmedical Therapeutics — Innovative medical devices designed to meet real clinical needs, combining science, know-how and therapeutic research.
Eoniq.fund is a generalist venture capital fund that invests in firms with Spanish based founders, being more proactive in terms of generating dealflow in regions outside of Madrid and Barcelona, and more reactive in those two hubs. They choose businesses with strong, ambitious teams, scalable business models, normally with a MVP already on themarket, and some traction, and are very centred on adding value to the startups that they invest in, over and above that of the funding itself.Eoniq.fund is headquartered in Sevilla, Andalucía.
Show more...Investment focus
- Industry: Artificial Intelligence, Health Care, Software
- Stage:Venture - Series Unknown, Seed, Pre-Seed
- Geography: Spain, United States
Investor stats
- Total investments: 41
- Round size: Seed $269k–$1.6M; Pre-Seed $224k–$772k; Venture - Series Unknown $115k–$1.7M
- Lead/follow: 63% lead, 37% follow
Portfolio highlights
- CeleBreak — Play football anytime, anywhere with CeleBreak. Join one of our pick-up games, trainings, tournaments or leagues! Download the app to get started
- Happymami — Happymami is a manufacturing company that is involved in the design, development and production of innovative baby-feeding bottles.
- Sensesbit — Sensesbit is a SaaS market research platform focused on sensory intelligence for the food and beverage industry, developed by TasteLab to analyze and predict product market acceptance . The tool integrates advanced statistical analysis, AI for benchmarking, and computer vision tools to manage sensory testing with consumers and trained panels. Learnmore about the platform on the official Sensesbit website.
Dozen Investments is a venture capital and private equity firm based in Spain.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Venture - Series Unknown, Pre-Seed
- Geography: Spain, United Kingdom
Investor stats
- Total investments: 38
- Round size: Seed $298k–$1.6M; Pre-Seed $651k–$1.2M; Venture - Series Unknown $506k–$7.4M
- Lead/follow: 47% lead, 53% follow
Portfolio highlights
- Wideum — Wideum is a Remote Service technology company, innovating in software applications for smartphones, tablets and smart glasses. Save Money and Time.
- Mettis AI — Revolutionizing Driver Certification with Real-Time, AI-Driven Accuracy Globally Scalable, Universally Accepted and Hardware-Agnostic
- STAMP — STAMP redefines Tax-Free in Europe. Instant VAT exemption for travelers. More sales, transparency, and control for merchants.
WA4STEAM is an all women angels investment group delivering worldwide access to seed capital for women entrepreneurs led startups in STEAM Science, Technology, Engineering , Architecture & Architecture and Mathematics
Show more...Investment focus
- Industry: Health Care, Biotechnology, Artificial Intelligence
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: Spain
Investor stats
- Total investments: 22
- Round size: Seed $392k–$4.2M; Pre-Seed $671k–$1.2M; Venture - Series Unknown $6.1M–$11M
- Lead/follow: 23% lead, 77% follow
Portfolio highlights
- Hair Up Laser — Making alopecia a problem of the past.
- Genbioma — Genbioma is a biotechnology company transforming microbiome science into clinically validated postbiotics that support metabolic health, improve glucose control, and naturally activate the GLP-1 pathway.
- Onalabs Inno-hub — Onalabs develops remote, continuous and non-invasive bio-medical devices to monitor through the skin and sweat several vital signs and some biomarkers. Onalabs is the first non-invasive device able to measure some chemical parameters present in sweat using miniaturised biosensors. Its non-invasive products based on wearable formats empower thepatients and their families to measure relevant vital signs and biomarkers anytime and anywhere, allowing them to detect and monitor early stages of possible clinical deterioration, which could prelude in earlier management strategies, resulting in shorter hospital stays and prevention of unnecessary treatments. The solutions are addressed to chronic patients, such as COPD, HF and Diabetes.
Bengkulutoto hadir sebagai solusi ideal bagi para pencinta angka jitu. Dengan predikat sebagai bandar togel online terlengkap, situs ini menawarkan keunggulan berupa proses deposit super cepat, serta sistem bermain yang adil dan transparan.
Show more...Investment focus
- Industry: Software, E-Commerce, FinTech
- Stage:Seed, Series A, Series B
- Geography: France, United States, Israel
Investor stats
- Total investments: 105
- Round size: Seed $1.1M–$9M; Series A $5.8M–$36M; Series B $18M–$74M
- Lead/follow: 2% lead, 98% follow
Portfolio highlights
- HUG — Join our global creative community to showcase & sell your art, connect with others, and access creator-friendly grants and education.
- Kate — Kate redefines everyday mobility by offering electric vehicles made in France.
- Multiwave Technologies — More than 2/3 of humanity has no access to medical imaging Our mission is to make MRI available globally, through our ultra-low field mobile device.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Ancora Finance Group is an international management consulting firm that offers unparalleled leadership, strategic, and operational advice. Their focus on financial services is deeply rooted in the DNA of their company as it comes from their people. They are based in London and Singapore, providing unparalleled leadership, strategic andoperational solutions for the financial services industry. Their experience, expertise, and approach combine consulting and knowledge transfer.
Show more...Investment focus
- Industry: Medical, Medical Device, Health Care
- Stage:Series A
- Geography: Spain, Germany
Investor stats
- Total investments: 3
- Round size: Series A $2.6M–$36M
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Koa Health — Make mental health manageable, treatable, and approachable for every industry and every individual with clinical-first care designed by experts. From evidence-based self-care and prevention through clinical treatment and therapy, Koa Health supports workforce wellbeing across the continuum.
- Atlas Medical Technologies — Atlas Medical Technologies is a manufacturing company that develops navigation systems for medical doctors for radiology and orthopedics.
Speedinvest is a globally active European venture capital firm built on a simple belief: many move more. From six offices across EMEA, our sector-focused investment teams back relentless founders from pre–Seed to Growth with long-term conviction, providing day-one access to our global network of corporate customers, experts, industry leaders, andtop-tier follow-on investors to scale smarter and faster. Building lasting companies like Bitpanda (Austria), Moove (Nigeria), Gigs (U.S.), Tide (UK), ARX Robotics (Germany), Wayflyer (Ireland), GoStudent (Austria), Seqera Labs (Spain), and Cylib (Germany) — together. Big ideas may start with one. But scaling and winning take The Power of More.
Show more...Investment focus
- Industry: Software, FinTech, Financial Services
- Stage:Seed, Series A, Pre-Seed
- Geography: United Kingdom, Germany, Austria
Investor stats
- Total investments: 603
- Round size: Seed $1M–$8M; Pre-Seed $713k–$3.8M; Series A $4.1M–$33M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $384M in 2022
Portfolio highlights
- Findery — Find and leave notes anywhere in the world, discover local knowledge, hidden secrets, and exciting stories. Share your travel knowledge, geoblog, or local news!
- Facility — Flexkeeping is a Hotel Operations Platform designed to help teams automate and collaborate like never before.
- Polaron — Material Design. Supercharged with AI.
We help create a path Seed to exit, we've been there. We're experienced tech investors. We partner with founders with vision, courage and the capacity to execute.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Series A, Seed
- Geography: Spain, United States, United Kingdom
Investor stats
- Total investments: 90
- Round size: Seed $1M–$6M; Series A $2.7M–$14M
- Lead/follow: 51% lead, 49% follow
- Last fund: May invest from a new fund soon — raised $293k in 2019
Portfolio highlights
- BEONx — Beonprice is one of the Travel Tech companies in Spain, committed to leading the future of revenue strategy. Agility, innovation and organization are the engines of the brand, with the aim of offering profitable innovation and being part of the DNA of each of its customers. Beonprice has developed HQI™, the only index in the hotel market thatmeasures the integral quality of a hotel in order to understand the competitive position and price elasticity of the demand in the market. Beonprice has more than 2,000 customers in more than 30 countries. Its RMS is successfully used by growing hotel chains such Bluebay, Hotelatelier, Iberostar, RIU, Labranda Hotels & Resorts, HM Resorts, Park Royal, Dreamplace, Catalonia, Room Mate, Orchid Hotels and many others.
- Articul8 — The Domain-Specific GenAI Platform, Purpose-Built for Your Data and Mission
- Flora — Flora Fertility is dedicated to empowering the next generation of parents by putting the control of reproductive health outcomes back where they belongs—in your hands. It aims to revolutionize how women's health and family building are approached, making fertility care more accessible, transparent, and personalized. By reimagining thefinancial and medical aspects of family planning, we help you navigate the journey to parenthood with greater confidence, ease, and support, ensuring that your fertility choices align with your personal goals and circumstances.
ICF Capital is a venture and growth capital management firm from ICF. ICF is a public financial institution founded in 1985 and owned by the Government of Catalonia. Our mission is to foster and improve access to funding for companies that operate in Catalonia in order to contribute to the growth of the region's economy while complementing theprivate financial sector. ICF provides funding to Catalan companies and entrepreneurs. They assist them in their development and growth, generating value for society at large. The institution offers companies a range of products and services in the area of corporate finance, focusing on loans and guarantees and venture capital investments. ICF operates via a parent company, two subsidiaries (IFEM and ICF Capital), and an investee (AVALIS). ICF, through IFEM, supports the creation and growth of innovative start-ups through the investment in venture capital funds for seed segments and co-investment with private investors through participative loans. ICF Capital, which manages closed-end UCITS and is authorized by Spain's National Securities Market Commission (CNMV), manages, nurtures, and advises public and/or private funds or venture capital firms that provide capital to Catalan companies. At present, ICF Capital directly manages 2 venture capital firms: ICF Capital Expansió II and ICF Venture Tech II.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Debt Financing, Seed
- Geography: Spain, United States, Mexico
Investor stats
- Total investments: 115
- Round size: Seed $1.2M–$6.9M; Debt Financing $110k–$1.7M
- Lead/follow: 23% lead, 77% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- Kintai — Kintai's a lending platform aiming to help small and medium companies with their funding needs. Based on a merchant cash advance model, companies can return their loans on a daily basis with low frictionless amounts.
- Covides — Covides is a prominent Spanish wine cooperative that integrates grape production, vinification, and international commercial distribution for local winegrowers.
- ATTSU — ATTSU is leader manufacturer of industrial steam boilers, thermal oil boilers and superheated water boilers. Available on a wide variety of fuels.
Bionova Capital, previously known as Hovione Capital, is a healthcare-focused venture capital firm, investing in early-stage life science companies. It was founded in 2015 by the shareholders of Hovione, one of the largest pharmaceutical companies in Portugal, with manufacturing and research operations in USA, Ireland, China and Portugal. BionovaCapital invests in groundbreaking therapeutics, medtech and digital health startups across Europe.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Portugal, United Kingdom, Spain
Investor stats
- Total investments: 9
- Round size: Seed $329k–$1.7M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Delox — Leader in advanced bio-discontamination solutions, Delox offers cutting-edge technology with vaporized hydrogen peroxide (VHP) for critical environments, laboratories, and healthcare. Validated safety and efficacy for a safer world.
- CellmAbs — Pharmaceutical Company, Biotechnology
- SolasCure — SolasCure aims to support healthcare professionals with wound care products that significantly improve the health and wellbeing of patients with chronic wounds.
ICF - Institut Català de Finances provides financial services.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Debt Financing, Seed
- Geography: Spain, Germany
Investor stats
- Total investments: 15
- Round size: Seed $2.4M–$2.9M; Debt Financing $1.7M–$12M
- Lead/follow: 73% lead, 27% follow
Portfolio highlights
- Ercros — Ercros is a chemical manufacturing company that focuses on the basic products for the chemical and pharmaceutical industries. The company diversified in three areas of activity such as the Pharmacy Division, the Chlorine Derivatives Division, and the Intermediate Chemistry Division. It maintains a leading position in the main markets in which it ispresent and exports almost half of its sales to more than 128 countries, mainly in the EU.Ercros was founded in 1989 and is headquartered in Barcelona, Spain.
- Super's Diana — Super’s Diana develops, manufactures, and markets medicines and supplements for swine, cattle, and poultry livestock in over 30 countries.
- Delta Renovables — Delta Renovables specializes in the creation, promotion, operation, and maintenance of renewable energy projects.
Seed Capital de Bizkaia is a Regional Council company affiliated to Biscay Regional Council's Department of Economic Development and Innovation (Departamento de Innovación y Promoción Económica de la Diputación Foral de Bizkaia) whose aim is to manage a Venture Capital Fund called “Seed Capital Bizkaia, F.C.R.“.
Show more...Investment focus
- Industry: Software, Biotechnology, Manufacturing
- Stage:Seed, Venture - Series Unknown
- Geography: Spain, Mexico, Belgium
Investor stats
- Total investments: 37
- Round size: Seed $119k–$2.8M; Venture - Series Unknown $1.2M–$18M
- Lead/follow: 24% lead, 76% follow
Portfolio highlights
- NNEAT — NNEAT's CTEM platform maps full attack surface with live threat intelligence. Fix exposures with agentic action. For mid-market companies & MSSPs.
- Walter Pack — Walter Pack is a manufacturer and seller of parts for the automotive industry.
- Sherpa.ai — Secure AI. Private Data. Sovereign Intelligence. Sherpa.ai platform enables secure distributed AI deployments across enterprises, governments, and regulat
MSM is a 45M€ early-stage impact VC fund. We invest in brave founders solving the world’s biggest social and environmental challenges.
Show more...Investment focus
- Industry: Information Technology, E-Commerce, B2B
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, Portugal, Germany
Investor stats
- Total investments: 54
- Round size: Seed $1.3M–$4.8M; Pre-Seed $244k–$3M; Series A $4.1M–$52M
- Lead/follow: 31% lead, 69% follow
Portfolio highlights
- Biorce — Meet the world's first AI clinical trials assistant! We bring innovative technologies to revolutionize healthcare and drug development faster & more efficiently
- Pollen — Electric mobility for lightweight vehicles is about to get simpler, more affordable and more reliable.
- Win-Win — We're WNWN Food Labs and we love food. We're creating delicious, sustainable and ethical alternatives to unsustainable and ethically dubious foods. We're starting with cacao-free chocolate. Changing chocolate? It's Win-Win #alt-chocolate #altchocolate #alt-universe #altuniverse #alt-protein
Alta Life Sciences is a leading multistage venture capital investment firm. Alta LS will invest in companies at all stages of development: from seed financing through commercial growth. Alta LS invests in all areas of life sciences including biotechnology, medical devices, diagnostics, genomics and digital health.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Venture - Series Unknown, Series B
- Geography: Spain, United States
Investor stats
- Total investments: 18
- Round size: Series A $3M–$33M; Series B $13M–$87M; Venture - Series Unknown $3.3M–$13M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
- Peptomyc — Peptomyc is a company focused on the development of a new generation of cell-penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. The company was founded in December 2014 and it is based on Dr. Soucek’s scientific research in Omomyc (the best direct Myc inhibitor known to date) over the last twenty years.Currently,cancer incidence in the world exceeds 14 million cases per year and results in 8 million deaths annually. Moreover, such numbers are forecast to rise by 75% over the next 20 years (World Cancer Report. International Agency for Research on Cancer 2014). At the moment, standard therapies include surgery, radiotherapy, chemotherapy, and, in a restricted subset of cancers, precision medicine. Unfortunately, very often these therapies fail, due to the development of resistance.Peptomyc has adopted a different strategy based on the inhibition of the oncoprotein Myc, which is found deregulated in the majority of human cancers. Myc holds a non-redundant function in cancer around which tumors cannot evolve, hence targeting Myc is the most promising therapeutic opportunity to date. Although Myc plays a central role in cancer there is currently no Myc inhibitor in the market.
- Ona Therapeutics — Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. Founded in 2019 by Salvador Aznar-Benitah and Valerie Vanhooren, it was a spin-off from ICREA and Advanced Studies, and the IRB Institute for Research in Biomedicine.
We are a venture capital fund investigating in Start-Ups solving the worlds biggest problems while building massive businesses.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Seed, Series A
- Geography: Sweden, United Kingdom, Germany
Investor stats
- Total investments: 106
- Round size: Seed $1.1M–$14M; Series A $4.2M–$56M
- Lead/follow: 31% lead, 69% follow
- Last fund: Likely still investing — raised $340M in 2024
Portfolio highlights
- Biorce — Biorce is an innovating HealthAI startup committed to transforming drug development through the use of artificial intelligence.
- CEEZER — CEEZER is the digital infrastructure to give companies access to the complex voluntary carbon market. Deliver true climate impact now!
- Endra — Endra is a software platform for mechanical, electrical, and plumbing (MEP) engineering that automates the design, modeling, and documentation of building systems. The platform generates 2D and 3D models, calculations, schedules, diagrams, and other engineering documentation from architectural and building design inputs. It supports disciplinessuch as electrical, fire alarm, HVAC, plumbing, and sprinkler system design, and integrates with Autodesk Revit and common CAD and BIM file formats. Endra uses artificial intelligence, simulation, and computational methods to assist with tasks such as system layout, cable routing, device placement, and documentation generation while helping engineers comply with applicable design standards and regulations. The platform is designed for MEP engineers and engineering firms seeking to reduce manual design and documentation work across construction projects.
Medical VC funding in Spain at a glance
Stats across 258 deals from 227 investors.
Access all 227 VC funds in Spain Medical startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical VC Funds in Spain investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 227 VC funds investing in Spain Medical startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!